• Clinical use of enterosorbents in pregnant women of high risk
To content Full text of article

Clinical use of enterosorbents in pregnant women of high risk

PERINATOLOGY AND PEDIATRIC. UKRAINE. 2018.1(73):36-40; doi 10.15574/PP.2018.73.36

Davydova Yu. V., Lymanska A. Yu.
SI «Institute of Pediatrics, Obstetrics and Gynaecology of NAMS of Ukraine», Kyiv, Ukraine

Efficiency improvement of congenital malformations, autoimmune, infectious-inflammatory, oncological diseases treatment allow significantly increasing the chances of women to become pregnant. At the same time, the latter leads to an increase drug intake during pregnancy, significantly increasing the risk of toxic maternal and fetal complications. To date, the efficiency of silicon dioxide administration in the complex treatment for poisoning, allergic reactions, hepatic and renal dysfunctions, hepatitis, infectious diseases in pregnant women has been proved. One of the modern enterosorbents containing silicon dioxide is Atoxil. High sorption activity, absence of contraindications and the possibility of combination with other drugs make it possible to administer the drug in obstetric practice to achieve high treatment efficiency while reducing its duration.
Key words: pregnancy, drug load, detoxication, enterosorbents.


1. Palii IH, Reznichenko IH. (2008). Suchasnyi pohliad na problemu enterosorbtsii: vybir optymalnoho preparatu. Liky Ukrainy. 6 (122):43—46.

2. Chuyko AA, Tertyih VA, Lobanov VV i dr. (2003). Meditsinskaya himiya i klinicheskoe primenenie dioksida kremniya. Pod red. A.A. Chuyko. Nats. akad. nauk Ukrainyi, In%t himii poverhnosti. Kiev: Naukova dumka: 175—178.

3. Abbasi M, Kowalewska-Grochowska K, Bahar MA, Kilani RT, Winkler-Lowen B, Guilbert LJ. (2003). Infection of placental trophoblasts by Toxoplasma gondii. J Infect Dis.188(4):608—616. https://doi.org/10.1086/377132; PMid:12898451

4. Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R, Mor G. (2004). Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol.173(7):4286—4296. https://doi.org/10.4049/jimmunol.173.7.4286; PMid:15383557

5. Cardenas I, Mor G, Aldo P, Lang SM, Stabach P, Sharp A, Romero R, Mazaki-Tovi S, Gervasi M, Means RE. (2011). Placental viral infection sensitizes to endotoxin-induced pre-term labor: A double hit hypothesis. Am J Reprod Immunol.65(2):110—117. https://doi.org/10.1111/j.1600-0897.2010.00908.x; PMid:20712808 PMCid:PMC3025809

6. Chen H, Yuan L, Tan J et al. (2008). Severe liver disease in pregnancy. Int J Gynaecol Obstet. 101(3):277—280. https://doi.org/10.1016/j.ijgo.2007.12.011; PMid:18321514

7. Collier AC, Ganley NA, Tingle MD, Blumenstein M, Marvin KW, Paxton JW, Mitchell MD, Keelan JA. (2002). UDP-glucuronyltransferase activity, expression and cellular localization in human placenta at term. Biochem Pharmacol.63:409—419. https://doi.org/10.1016/S0006-2952(01)00890-5

8. Evseenko D, Paxton JW, Keelan JA. (2006). Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol. 2:51—69. https://doi.org/10.1517/17425255.2.1.51; PMid:16863468

9. Glantz A, Marschall HU, Lammert F, Mattsson LA. (2005). Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology.42(6):1399—1405. https://doi.org/10.1002/hep.20952; PMid:16317669

10. Hay JE. (2008). Liver disease in pregnancy. Hepatology.47(3):1676—79. https://doi.org/10.1002/hep.22130; PMid:18265410

11. Iyengar GV, Rapp A. (2001). Human placenta as a 'dual' biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 3: toxic trace elements in placenta and placenta as a biomarker for these elements. Sci Total Environ.280:221—238. https://doi.org/10.1016/S0048-9697(01)00827-0; https://doi.org/10.1016/S0048-9697(01)00825-7; https://doi.org/10.1016/S0048-9697(01)00826-9

12. Robbins JR, Skrzypczynska KM, Zeldovich VB, Kapidzic M, Bakardjiev AI. (2010). Placental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes. PLoS Pathog.6(1):e1000732. https://doi.org/10.1371/journal.ppat.1000732; PMid:20107601 PMCid:PMC2809766

13. Su GL. (2008). Pregnancy and liver disease. Curr Gastroenterol Rep. 10(1):1521—27. https://doi.org/10.1007/s11894-008-0004-0